A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2

Conditions

Seasonal Allergic Rhinitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Luo Zhang) · dr.luozhang@139.com · +86-010-65141136
Contact: Principal Investigator (Luo Zhang)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure

Seasonal Allergic Rhinitis (SAR)

Abroad (travel likely)RecruitingPHASE2

Mississauga, Canada